U.S. adults’ reasons for changing their degree of willingness to vaccinate against COVID-19

INTRODUCTION: COVID-19 vaccines significantly reduce the risk of complications and hospitalizations due to this virus. When COVID-19 vaccines first became commercially available, roughly 30% of U.S. adults reported being hesitant to receive these newly developed vaccines, and 15% said they would not...

Descripción completa

Detalles Bibliográficos
Autores principales: Koskan, Alexis M., Teeter, Benjamin S., Daniel, Casey L., LoCoco, Iris E., Jensen, Ulrich T., Ayers, Stephanie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852802/
https://www.ncbi.nlm.nih.gov/pubmed/36694558
http://dx.doi.org/10.1007/s10389-023-01819-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852802/
https://www.ncbi.nlm.nih.gov/pubmed/36694558
http://dx.doi.org/10.1007/s10389-023-01819-2

Ejemplares similares